Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120M
-
Number of holders
-
232
-
Total 13F shares, excl. options
-
128M
-
Shares change
-
+487K
-
Total reported value, excl. options
-
$3.71B
-
Value change
-
-$47.5M
-
Put/Call ratio
-
1.39
-
Number of buys
-
121
-
Number of sells
-
-125
-
Price
-
$29.08
Significant Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q4 2024
301 filings reported holding RNA - Avidity Biosciences, Inc. - Common Stock as of Q4 2024.
Avidity Biosciences, Inc. - Common Stock (RNA) has 232 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 128M shares
.
Largest 10 shareholders include FMR LLC (16.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (11M shares), BlackRock, Inc. (9.93M shares), VANGUARD GROUP INC (9.43M shares), WELLINGTON MANAGEMENT GROUP LLP (8.11M shares), RTW INVESTMENTS, LP (7.93M shares), Avoro Capital Advisors LLC (7.5M shares), JANUS HENDERSON GROUP PLC (7.05M shares), RA CAPITAL MANAGEMENT, L.P. (6.3M shares), and STATE STREET CORP (4.6M shares).
This table shows the top 232 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.